{"id":"https://openalex.org/W3010304596","doi":"https://doi.org/10.1099/acmi.fis2019.po0187","title":"In vitro activity of fosfomycin, and synergy in combination, against Gram negative bloodstream infection isolates in a UK hospital","display_name":"In vitro activity of fosfomycin, and synergy in combination, against Gram negative bloodstream infection isolates in a UK hospital","publication_year":2020,"publication_date":"2020-02-01","ids":{"openalex":"https://openalex.org/W3010304596","doi":"https://doi.org/10.1099/acmi.fis2019.po0187","mag":"3010304596"},"language":"en","primary_location":{"id":"doi:10.1099/acmi.fis2019.po0187","doi":"https://doi.org/10.1099/acmi.fis2019.po0187","is_oa":true,"landing_page_url":"https://doi.org/10.1099/acmi.fis2019.po0187","pdf_url":null,"source":{"id":"https://openalex.org/S4210207429","display_name":"Access Microbiology","issn_l":"2516-8290","issn":["2516-8290"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1"],"host_organization":"https://openalex.org/P4310320497","host_organization_name":"Microbiology Society","host_organization_lineage":["https://openalex.org/P4310320497"],"host_organization_lineage_names":["Microbiology Society"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Access Microbiology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1099/acmi.fis2019.po0187","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058151068","display_name":"Joseph Suich","orcid":"https://orcid.org/0000-0001-5543-6555","observed_orcids":["https://orcid.org/0000-0001-5543-6555"]},"institutions":[{"id":"https://openalex.org/I191240316","display_name":"University of Hull","ror":"https://ror.org/04nkhwh30","country_code":"GB","type":"education","lineage":["https://openalex.org/I191240316"]},{"id":"https://openalex.org/I4210113900","display_name":"York Teaching Hospital NHS Foundation Trust","ror":"https://ror.org/027e4g787","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210113900"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Joseph Suich","raw_affiliation_strings":["Hull University Teaching Hospitals NHS Trust, UK, Hull","York Teaching Hospital NHS Trust, UK, York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hull University Teaching Hospitals NHS Trust, UK, Hull","institution_ids":["https://openalex.org/I191240316"]},{"raw_affiliation_string":"York Teaching Hospital NHS Trust, UK, York","institution_ids":["https://openalex.org/I4210113900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082394230","display_name":"Damian P. C. Mawer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113900","display_name":"York Teaching Hospital NHS Foundation Trust","ror":"https://ror.org/027e4g787","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210113900"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Damian Mawer","raw_affiliation_strings":["York Teaching Hospital NHS Trust, UK, York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"York Teaching Hospital NHS Trust, UK, York","institution_ids":["https://openalex.org/I4210113900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059769579","display_name":"Marian Van der Woude","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I69768126","display_name":"Hull York Medical School","ror":"https://ror.org/0003e4m70","country_code":"GB","type":"education","lineage":["https://openalex.org/I69768126"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Marian Van der Woude","raw_affiliation_strings":["Hull York Medical School, UK, York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hull York Medical School, UK, York","institution_ids":["https://openalex.org/I69768126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110670522","display_name":"Deborah Wearmouth","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I191240316","display_name":"University of Hull","ror":"https://ror.org/04nkhwh30","country_code":"GB","type":"education","lineage":["https://openalex.org/I191240316"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Deborah Wearmouth","raw_affiliation_strings":["Hull University Teaching Hospitals NHS Trust, UK, Hull"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hull University Teaching Hospitals NHS Trust, UK, Hull","institution_ids":["https://openalex.org/I191240316"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Alison Eyre","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I191240316","display_name":"University of Hull","ror":"https://ror.org/04nkhwh30","country_code":"GB","type":"education","lineage":["https://openalex.org/I191240316"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Alison Eyre","raw_affiliation_strings":["Hull University Teaching Hospitals NHS Trust, UK, Hull"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hull University Teaching Hospitals NHS Trust, UK, Hull","institution_ids":["https://openalex.org/I191240316"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103853949","display_name":"Phillipa Burns","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I69768126","display_name":"Hull York Medical School","ror":"https://ror.org/0003e4m70","country_code":"GB","type":"education","lineage":["https://openalex.org/I69768126"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Phillipa Burns","raw_affiliation_strings":["Hull York Medical School, UK, York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hull York Medical School, UK, York","institution_ids":["https://openalex.org/I69768126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112511368","display_name":"Ton Smeets","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ton Smeets","raw_affiliation_strings":["Nordic Pharma B. V., Baam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nordic Pharma B. V., Baam, Netherlands","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087716379","display_name":"Gavin D Barlow","orcid":"https://orcid.org/0000-0002-4018-6685","observed_orcids":["https://orcid.org/0000-0002-4018-6685"]},"institutions":[{"id":"https://openalex.org/I191240316","display_name":"University of Hull","ror":"https://ror.org/04nkhwh30","country_code":"GB","type":"education","lineage":["https://openalex.org/I191240316"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Gavin Barlow","raw_affiliation_strings":["Hull University Teaching Hospitals NHS Trust, UK, Hull"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hull University Teaching Hospitals NHS Trust, UK, Hull","institution_ids":["https://openalex.org/I191240316"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":700,"currency":"GBP","value_usd":858},"apc_paid":{"value":700,"currency":"GBP","value_usd":858},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"2","issue":"2","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12167","display_name":"Bacterial Identification and Susceptibility Testing","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fosfomycin","display_name":"fosfomycin","score":1.0},{"id":"https://openalex.org/keywords/gram-negative-bacteremia","display_name":"gram-negative bacteremia","score":0.8259999752044678},{"id":"https://openalex.org/keywords/synergistic-antimicrobial-activity","display_name":"antimicrobial synergy","score":0.7799999713897705},{"id":"https://openalex.org/keywords/combination-antibiotic-therapy","display_name":"combination antibiotic therapy","score":0.5609999895095825},{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.7310000061988831},{"id":"https://openalex.org/keywords/extended-spectrum-beta-lactamase","display_name":"extended-spectrum beta-lactamase","score":0.8920000195503235},{"id":"https://openalex.org/keywords/carbapenem-resistance","display_name":"carbapenem resistance","score":0.9490000009536743},{"id":"https://openalex.org/keywords/enterobacteriaceae","display_name":"Enterobacteriaceae","score":0.8899999856948853},{"id":"https://openalex.org/keywords/piperacillin-tazobactam","display_name":"piperacillin-tazobactam","score":0.9010000228881836},{"id":"https://openalex.org/keywords/ceftazidime-avibactam","display_name":"ceftazidime-avibactam","score":0.9940000176429749},{"id":"https://openalex.org/keywords/temocillin","display_name":"temocillin","score":0.9929999709129333},{"id":"https://openalex.org/keywords/aztreonam","display_name":"aztreonam","score":0.9850000143051147},{"id":"https://openalex.org/keywords/meropenem","display_name":"meropenem","score":0.9900000095367432},{"id":"https://openalex.org/keywords/tigecycline","display_name":"tigecycline","score":0.9380000233650208},{"id":"https://openalex.org/keywords/in-vitro-susceptibility","display_name":"in vitro susceptibility","score":0.4779999852180481}],"concepts":[{"id":"https://openalex.org/C2778897966","wikidata":"https://www.wikidata.org/wiki/Q183554","display_name":"Fosfomycin","level":3,"score":0.9963241815567017},{"id":"https://openalex.org/C2780416669","wikidata":"https://www.wikidata.org/wiki/Q418546","display_name":"Aztreonam","level":5,"score":0.7362895011901855},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.6478395462036133},{"id":"https://openalex.org/C2779375183","wikidata":"https://www.wikidata.org/wiki/Q421670","display_name":"Meropenem","level":4,"score":0.6311115026473999},{"id":"https://openalex.org/C2777027569","wikidata":"https://www.wikidata.org/wiki/Q420595","display_name":"Tigecycline","level":3,"score":0.6264174580574036},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.6191079020500183},{"id":"https://openalex.org/C2779259085","wikidata":"https://www.wikidata.org/wiki/Q418946","display_name":"Colistin","level":3,"score":0.5871570706367493},{"id":"https://openalex.org/C2778266534","wikidata":"https://www.wikidata.org/wiki/Q423376","display_name":"Tazobactam","level":5,"score":0.5808039307594299},{"id":"https://openalex.org/C2776685102","wikidata":"https://www.wikidata.org/wiki/Q410897","display_name":"Carbapenem","level":3,"score":0.5616501569747925},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.43386176228523254},{"id":"https://openalex.org/C2778193466","wikidata":"https://www.wikidata.org/wiki/Q423787","display_name":"Piperacillin","level":4,"score":0.42608463764190674},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.39880767464637756},{"id":"https://openalex.org/C94665300","wikidata":"https://www.wikidata.org/wiki/Q63391344","display_name":"Antibiotic resistance","level":3,"score":0.2528219223022461},{"id":"https://openalex.org/C2779631663","wikidata":"https://www.wikidata.org/wiki/Q425152","display_name":"Imipenem","level":4,"score":0.14083930850028992},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.0968303382396698},{"id":"https://openalex.org/C2777637488","wikidata":"https://www.wikidata.org/wiki/Q31856","display_name":"Pseudomonas aeruginosa","level":3,"score":0.06284737586975098},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1099/acmi.fis2019.po0187","doi":"https://doi.org/10.1099/acmi.fis2019.po0187","is_oa":true,"landing_page_url":"https://doi.org/10.1099/acmi.fis2019.po0187","pdf_url":null,"source":{"id":"https://openalex.org/S4210207429","display_name":"Access Microbiology","issn_l":"2516-8290","issn":["2516-8290"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1"],"host_organization":"https://openalex.org/P4310320497","host_organization_name":"Microbiology Society","host_organization_lineage":["https://openalex.org/P4310320497"],"host_organization_lineage_names":["Microbiology Society"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Access Microbiology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1099/acmi.fis2019.po0187","doi":"https://doi.org/10.1099/acmi.fis2019.po0187","is_oa":true,"landing_page_url":"https://doi.org/10.1099/acmi.fis2019.po0187","pdf_url":null,"source":{"id":"https://openalex.org/S4210207429","display_name":"Access Microbiology","issn_l":"2516-8290","issn":["2516-8290"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1"],"host_organization":"https://openalex.org/P4310320497","host_organization_name":"Microbiology Society","host_organization_lineage":["https://openalex.org/P4310320497"],"host_organization_lineage_names":["Microbiology Society"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Access Microbiology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4225104222","https://openalex.org/W161189183","https://openalex.org/W2470176545","https://openalex.org/W1985985925","https://openalex.org/W2092992319","https://openalex.org/W2903962747","https://openalex.org/W3133185361","https://openalex.org/W2755886574","https://openalex.org/W2019288208","https://openalex.org/W2167707052"],"abstract_inverted_index":{"Background:Fosfomycin":[0],"has":[1],"retained":[2],"activity":[3,64],"against":[4,14],"many":[5],"multi-drug":[6],"resistant":[7,102],"(MDR)":[8],"Gram-negatives,":[9],"and":[10,20,69,132,166,171,184],"may":[11],"be":[12,220],"useful":[13],"extended":[15],"spectrum":[16],"beta-lactamase":[17],"(ESBL)":[18],"producing":[19],"carbapenem-resistant":[21],"Enterobacteriaceae.":[22],"There":[23],"are":[24],"few":[25],"data":[26],"from":[27],"the":[28,31,41,62,137],"UK":[29],"on":[30,120],"susceptibility":[32],"of":[33,43,46,65,117,211,232],"invasive":[34],"Gram-negative":[35,58],"isolates":[36,143,153],"to":[37,114,146,238],"fosfomycin,":[38],"especially":[39],"in":[40,55,90,134,207,240],"era":[42],"increasing":[44],"use":[45],"oral":[47],"fosfomycin":[48,79,147,165,224],"for":[49,78,88,156,204,214],"UTIs.":[50],"Materials/methods:":[51],"1.":[52],"We":[53],"evaluated,":[54],"100":[56],"consecutive":[57],"bloodstream":[59],"infections":[60],"(BSI),":[61],"in-vitro":[63],"fosfomycin.":[66],"Disc":[67],"diffusion":[68],"MIC":[70,149],"test":[71,150],"strip":[72],"methods":[73],"applying":[74],"revised":[75],"EUCAST":[76],"guidelines":[77],"were":[80,97,129,144,154,202,235],"used.":[81],"2.":[82],"A":[83],"secondary":[84],"objective":[85],"was":[86,160,177,190,196],"testing":[87],"synergy":[89,140,157],"combination":[91,135,225],"with":[92,181,192,228],"10":[93],"further":[94],"antibiotics.":[95],"Isolates":[96],"selected":[98],"if:":[99],"a)":[100],"Fosfomycin":[101],"b)":[103],"AMP-C/ESBL/carbapenemase":[104],"producers":[105],"(or":[106],"carbapenem":[107],"resistant)":[108],"c)":[109],"\u2018MDR\u2019:":[110],"defined":[111],"as":[112],"\u2018resistance":[113],"\u22653":[115],"classes":[116],"antibiotics\u2019":[118],"(based":[119],"prior":[121],"routine":[122],"sensitivity":[123],"testing).":[124],"For":[125],"eligible":[126,155],"isolates,":[127],"MICs":[128],"determined":[130],"individually,":[131],"subsequently":[133],"using":[136,223],"MTS":[138],"\u2018cross\u2019":[139],"method.":[141],"Results:96/100":[142],"susceptible":[145],"by":[148],"strip.":[151],"30/100":[152],"testing.":[158],"Synergy":[159],"most":[161,178],"commonly":[162,179],"detected":[163,180,203],"between":[164],"piperacillin/tazobactam":[167],"(32.1%),":[168],"ceftazidime/avibactam":[169],"(30%),":[170],"temocillin":[172],"(28.5%).":[173],"An":[174],"additive":[175,200],"effect":[176],"aztreonam":[182],"(85.7%)":[183],"meropenem":[185],"(82.1%),":[186],"but":[187],"100%":[188],"indifference":[189],"found":[191],"tigecycline.":[193],"No":[194],"antagonism":[195],"identified.":[197],"Conclusions:Synergistic":[198],"or":[199],"effects":[201],"beta-lactam/fosfomycin":[205],"combinations":[206,218],"a":[208,229],"high":[209],"proportion":[210],"isolates;":[212],">80%":[213],"all":[215],"suggesting":[216],"such":[217],"should":[219],"preferred":[221],"when":[222],"therapy.":[226],"Agents":[227],"different":[230],"site":[231],"antibiotic":[233],"action,":[234],"more":[236],"likely":[237],"result":[239],"indifference.":[241]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2020-03-13T00:00:00"}